BTL-191118

N/A

Report date: 2022/01/17 16:32:01
NME

Base Information

Drug NameBTL-191118
Drug Alias NameBTL-191118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBerylrx Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBerylrx Therapeutics
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Cirrhosis, Biliary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A